These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35275912)

  • 1. Alginate microencapsulation of an attenuated O-antigen mutant of Francisella tularensis LVS as a model for a vaccine delivery vehicle.
    Freudenberger Catanzaro KC; Lahmers KK; Allen IC; Inzana TJ
    PLoS One; 2022; 17(3):e0259807. PubMed ID: 35275912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
    Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA
    Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine.
    Kim TH; Pinkham JT; Heninger SJ; Chalabaev S; Kasper DL
    J Infect Dis; 2012 Apr; 205(7):1056-65. PubMed ID: 21969334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.
    Li J; Ryder C; Mandal M; Ahmed F; Azadi P; Snyder DS; Pechous RD; Zahrt T; Inzana TJ
    Microbiology (Reading); 2007 Sep; 153(Pt 9):3141-3153. PubMed ID: 17768257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a live attenuated vaccine candidate for tularemia prophylaxis.
    Mahawar M; Rabadi SM; Banik S; Catlett SV; Metzger DW; Malik M; Bakshi CS
    PLoS One; 2013; 8(4):e61539. PubMed ID: 23613871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
    Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.
    Conlan JW; Shen H; Golovliov I; Zingmark C; Oyston PC; Chen W; House RV; Sjöstedt A
    Vaccine; 2010 Feb; 28(7):1824-31. PubMed ID: 20018266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.
    Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL
    Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.
    Jia Q; Bowen R; Sahakian J; Dillon BJ; Horwitz MA
    Infect Immun; 2013 May; 81(5):1550-61. PubMed ID: 23439306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further Characterization of the Capsule-Like Complex (CLC) Produced by
    Champion AE; Bandara AB; Mohapatra N; Fulton KM; Twine SM; Inzana TJ
    Front Cell Infect Microbiol; 2018; 8():182. PubMed ID: 29963499
    [No Abstract]   [Full Text] [Related]  

  • 12. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia.
    Golovliov I; Twine SM; Shen H; Sjostedt A; Conlan W
    PLoS One; 2013; 8(11):e78671. PubMed ID: 24236032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.
    Skyberg JA; Rollins MF; Samuel JW; Sutherland MD; Belisle JT; Pascual DW
    Infect Immun; 2013 Sep; 81(9):3099-105. PubMed ID: 23774604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.
    Ray HJ; Cong Y; Murthy AK; Selby DM; Klose KE; Barker JR; Guentzel MN; Arulanandam BP
    Clin Vaccine Immunol; 2009 Apr; 16(4):444-52. PubMed ID: 19211773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.
    McCormick AA; Shakeel A; Yi C; Kaur H; Mansour AM; Bakshi CS
    PLoS One; 2018; 13(4):e0194614. PubMed ID: 29684046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
    Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.
    Hickey AJ; Hazlett KR; Kirimanjeswara GS; Metzger DW
    Vaccine; 2011 Sep; 29(40):6941-7. PubMed ID: 21803089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity.
    Okan NA; Chalabaev S; Kim TH; Fink A; Ross RA; Kasper DL
    mBio; 2013 Feb; 4(1):e00638-12. PubMed ID: 23404403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity.
    Cole LE; Elkins KL; Michalek SM; Qureshi N; Eaton LJ; Rallabhandi P; Cuesta N; Vogel SN
    J Immunol; 2006 Jun; 176(11):6888-99. PubMed ID: 16709849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis.
    Sebastian S; Pinkham JT; Lynch JG; Ross RA; Reinap B; Blalock LT; Conlan JW; Kasper DL
    Vaccine; 2009 Jan; 27(4):597-605. PubMed ID: 19022323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.